These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differentiated and dose-related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock. Konrad D; Oldner A; Rossi P; Wanecek M; Rudehill A; Weitzberg E Crit Care Med; 2004 May; 32(5):1192-9. PubMed ID: 15190972 [TBL] [Abstract][Full Text] [Related]
3. Combination of intravenously infused methylene blue and inhaled nitric oxide ameliorates endotoxin-induced lung injury in awake sheep. Kirov MY; Evgenov OV; Bjertnaes LJ Crit Care Med; 2003 Jan; 31(1):179-86. PubMed ID: 12545013 [TBL] [Abstract][Full Text] [Related]
4. Tezosentan-induced attenuation of lung injury in endotoxemic sheep is associated with reduced activation of protein kinase C. Kuklin V; Kirov M; Sovershaev M; Andreasen T; Ingebretsen OC; Ytrehus K; Bjertnaes L Crit Care; 2005 Jun; 9(3):R211-7. PubMed ID: 15987392 [TBL] [Abstract][Full Text] [Related]
5. Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension. Fitzgerald RK; Oishi P; Ovadia B; Ross GA; Reinhartz O; Johengen MJ; Fineman JR Pediatr Crit Care Med; 2004 Nov; 5(6):571-7. PubMed ID: 15530195 [TBL] [Abstract][Full Text] [Related]
6. Effects of endothelin receptor antagonism on acute lung injury induced by chlorine gas. Wang J; Oldner A; Winskog C; Edston E; Walther SM Crit Care Med; 2006 Jun; 34(6):1731-7. PubMed ID: 16625121 [TBL] [Abstract][Full Text] [Related]
7. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure. Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476 [TBL] [Abstract][Full Text] [Related]
8. Effects of the dual endothelin receptor antagonist tezosentan and hypertonic saline/dextran on porcine endotoxin shock. Somell A; Weitzberg E; Suneson A; Sollevi A; Hjelmqvist H Acta Physiol (Oxf); 2007 Aug; 190(4):291-302. PubMed ID: 17498196 [TBL] [Abstract][Full Text] [Related]
9. Effects of adenosine on extravascular lung water content in endotoxemic pigs. Kutzsche S; Lyberg T; Bjertnaes LJ Crit Care Med; 2001 Dec; 29(12):2371-3276. PubMed ID: 11801842 [TBL] [Abstract][Full Text] [Related]
10. Acute cardiopulmonary effects of a dual-endothelin receptor antagonist on oleic acid-induced pulmonary arterial hypertension in dogs. Wang L; Zhu DM; Su X; Bai CX; Ware LB; Matthay MA Exp Lung Res; 2004; 30(1):31-42. PubMed ID: 14967602 [TBL] [Abstract][Full Text] [Related]
11. Heparin-binding protein (HBP/CAP37) - a link to endothelin-1 in endotoxemia-induced pulmonary oedema? Persson BP; Halldorsdottir H; Lindbom L; Rossi P; Herwald H; Weitzberg E; Oldner A Acta Anaesthesiol Scand; 2014 May; 58(5):549-59. PubMed ID: 24611481 [TBL] [Abstract][Full Text] [Related]
13. Effects of tezosentan, a dual endothelin receptor antagonist, on the cardiovascular and renal systems of neonatal piglets during endotoxic shock. Chin A; Radhakrishnan J; Fornell L; John E J Pediatr Surg; 2002 Mar; 37(3):482-7. PubMed ID: 11877672 [TBL] [Abstract][Full Text] [Related]
14. Tezosentan counteracts endotoxin-induced pulmonary edema and improves gas exchange. Rossi P; Wanecek M; Konrad D; Oldner A Shock; 2004 Jun; 21(6):543-8. PubMed ID: 15167683 [TBL] [Abstract][Full Text] [Related]
15. A novel leukotriene B4-receptor antagonist in endotoxin shock: a prospective, controlled trial in a porcine model. Fink MP; O'Sullivan BP; Menconi MJ; Wollert PS; Wang H; Youssef ME; Fleisch JH Crit Care Med; 1993 Dec; 21(12):1825-37. PubMed ID: 8252886 [TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure. Torre-Amione G; Young JB; Durand J; Bozkurt B; Mann DL; Kobrin I; Pratt CM Circulation; 2001 Feb; 103(7):973-80. PubMed ID: 11181472 [TBL] [Abstract][Full Text] [Related]
17. Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction. Clozel M; Qiu C; Qiu CS; Hess P; Clozel JP J Am Coll Cardiol; 2002 Jan; 39(1):142-7. PubMed ID: 11755300 [TBL] [Abstract][Full Text] [Related]
18. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. McMurray JJ; Teerlink JR; Cotter G; Bourge RC; Cleland JG; Jondeau G; Krum H; Metra M; O'Connor CM; Parker JD; Torre-Amione G; van Veldhuisen DJ; Lewsey J; Frey A; Rainisio M; Kobrin I; JAMA; 2007 Nov; 298(17):2009-19. PubMed ID: 17986694 [TBL] [Abstract][Full Text] [Related]
19. Tezosentan reduces the microvascular filtration coefficient in isolated lungs from rats subjected to cecum ligation and puncture. Kuklin V; Sovershaev M; Andreasen T; Skogen V; Ytrehus K; Bjertnaes L Crit Care; 2005; 9(6):R677-86. PubMed ID: 16280068 [TBL] [Abstract][Full Text] [Related]
20. The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock. Wanecek M; Rudehill A; Hemsén A; Lundberg JM; Weitzberg E Crit Care Med; 1997 May; 25(5):848-57. PubMed ID: 9187606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]